杰拉尔德·斯威斯是福里尔·拉德纳律师事务所的退休合伙人及知识产权律师。他专注于战略咨询领域，为生物制药、生命科学及医疗器械领域的客户提供知识产权战略实施服务。杰拉尔德拥有约35年专利申请经验，主要涉及小分子、化学工艺、酶制剂及医疗器械的知识产权保护。 尤其在治疗癌症、贫血、血栓及炎症疾病的新型化学实体骨架领域，他处理过大量知识产权事务。他曾任职于该律所的化学、生物技术与制药业务部。
In addition to his patent prosecution skills, Gerald’ legal experience included developing international patent strategies for critical lead compounds and new discovery platforms, addressing due diligence, freedom to operate, validity and infringement/non-infringement analyses, as well as patent procurement.
Gerald started his career as a medicinal research chemist at Schering Corporation, where he worked in the synthesis of small molecules in the pharmaceutical arena. His research focused on anti-inflammatory and anti-hypertensive compounds.
奖项与表彰
In recognition of his experience, he has been Peer Review Rated as AV® Preeminent™, the highest performance rating in Martindale-Hubbell’s peer review rating system. He has been selected for inclusion in The Best Lawyers in America® since 2012 and The Legal 500 also recognized Gerald in 2011 and 2013 as one of the leading lawyers in the U.S. for patent prosecution: utility and design patents. He was also recognized among IAM Patent 1000 – The World’s Leading Patent Practitioners (2012-2016). In 2015, Gerald was named an IP Star by Managing Intellectual Property magazine. Past clients have noted his writing skills and strategic counseling, both of which have made Gerald highly sought-after by pharmaceutical companies.